Introduction: The prospects for using magnetic hyperthermia in cancer therapy are largely determined by the properties of the magnetic nanoparticles (MNPs), including heating efficiency, biosafety, and bioresorption capacity. In this study, we performed a comparative in vivo assessment of the toxicity and bioresorption of Fe3O4- and Zn0.2Mn0.8Fe2O4-based MNPs stabilized with oleic acid/sodium oleate (OA) or amino-functionalized silicon dioxide (SiO2–NH2). Materials and Methods: Four types of MNPs were synthesized: Fe3O4@OA, Zn0.2Mn0.8Fe2O4@OA, Fe3O4@SiO2–NH2 and Zn0.2Mn0.8Fe2O4@SiO2–NH2. The particles were characterized using DLS, TEM and vibrating sample magnetometry. Acute toxicity was evaluated in BALB/c mice after a single intraperitoneal or intramuscular administration. Biosafety and bioresorption after intramuscular administration were assessed on days 2, 14, and 90, using hematological and biochemical blood tests, histological examination, sample magnetization, and total iron content in tissues. Results and Discussion: After intraperitoneal administration, the LD50 values were 904 mg/kg for Fe3O4@OA, 1145 mg/kg for Zn0.2Mn0.8Fe2O4@OA, and 2955 mg/kg for Zn0.2Mn0.8Fe2O4@SiO2–NH2, whereas the LD50 for Fe3O4@SiO2–NH2 was not reached. After intramuscular administration at a dose of 1020 mg/kg, neither deaths nor pronounced systemic toxicity was observed. By day 90, MNPs with an oleic acid/sodium oleate-based coating showed a decrease in magnetic signal and total iron content at the injection site, whereas SiO2–NH2-coated nanoparticles remained in muscle tissue. Conclusion: The study showed that the chemical nature of the coating is one of the main factors determining the toxicity and bioresorption of Fe3O4 and Zn0.2Mn0.8Fe2O4 MNPs. Particles with a SiO2–NH2 coating were characterized by lower acute toxicity after intraperitoneal administration compared with MNPs coated with oleic acid/sodium oleate. After intramuscular administration at a dose of 1020 mg/kg, neither mortality nor pronounced signs of systemic toxicity were detected for any type of MNPs. It was also shown that the coating type affects the possibility and rate of bioresorption: after intramuscular administration at a dose of 256 mg/kg, MNPs with a SiO2–NH2 coating remained at the injection site for 90 days, whereas the oleic acid/sodium oleate-based coating promoted bioresorption.